Back to top
Top

Medication, Active

Performance/Reporting Period
2019
QDM Datatype (QDM Version 5.3):

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set is being taken by the patient. Keep in mind that when this datatype is used with timing relationships, the criterion is looking for a medication being taken for the time frame indicated by the timing relationships.

Timing: The Relevant Period addresses:

  • startTime - when the medication is first known to be used (generally the time of entry on the medication list),
  • stopTime - when the medication is discontinued (generally, the time discontinuation is recorded on the medication list)

 

QDM Category (QDM Version 5.3)

Medication

Medication represents clinical drugs or chemical substances intended for use in the medical diagnosis, cure, treatment, or prevention of disease. Medications are defined as direct referenced values or value sets containing values derived from code systems such as RxNorm.

QDM Attributes

Dosage

Details of how medication is taken or is to be taken, i.e., the quantity (mg, cc, tablets) to be taken at a single administration.

Frequency

Indicates how frequently the medication or substance: is administered to a patient for an active medication (Medication, Active), was administered to the patient (Medication, Administered and Substance, Administered), should be taken by the patient or administered to the patient (Medication, Discharge; Medication, Dispensed; Medication, Order; and Substance, Order), is recommended to be given to the patient (Substance, Recommended).

Relevant Period

Relevant Period addresses the time between the start of an action to the end of an action. Each datatype using relevant period defines specific definitions for the start and stop time for the action listed.

Route

Refers to the path by which the medication or substance should be taken into the body system, such as intradermally, intrathecally, intramuscularly, intranasally, intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally.
Last Updated: Mar 31, 2020